Abdelilah Aboussekhra

15PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer cell biologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 17, 2026
Eugenoplatin (a phyto-chemo drug conjugate) targets cancer stem cells through inhibition of the β-catenin signaling in triple-negative breast cancer cells.

Noura N Alraouji, Basem Al-Otaibi, Mohd Yasir Khan

|Sep 09, 2025
A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort study.

Syed S Islam, Taher Al-Tweigeri, Asma Tulbah

|Aug 24, 2024
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells.

Noura N Alraouji, Dilek Colak, Falah H Al-Mohanna

|Apr 04, 2024
Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells.

Syed S Islam, Falah H Al-Mohanna, Iman M Yousef

|Jan 31, 2024
Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancer.

Syed S Islam, Taher Al-Tweigeri, Layla Al-Harbi

|Aug 09, 2022
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma.

Syed S Islam, Khawlah Qassem, Shafiqul Islam

Pageof 3

Frequent Collaborators

3 joint publications

Syed S Islam